Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis

Published:2020-01 Issue: Volume:145 Page:102817
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Parmar Ambica^ORCID,Chaves-Porras Jorge,Saluja Ronak,Perry Kaitlyn,Rahmadian Amanda P.,Santos Seanthel Delos,Ko Yoo-Joung,Berry Scott,Doherty Mark,Chan Kelvin K.W.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. SEER Cancer Statistics Review, 1975-2016;Howlader,2018

3. Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival;Morganti;BMC Cancer,2019

4. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial;Neoptolemos;Lancet,2001

5. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N. Engl. J. Med.,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic value of VISTA combined with imaging in pancreatic cancer patients;2024-01-15

2. Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline;Current Oncology;2023-07-08

3. Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall Survival;Clinical Oncology;2023-05

4. Postoperative complications and short-term prognosis of laparoscopic pancreaticoduodenectomy vs. open pancreaticoduodenectomy for treating pancreatic ductal adenocarcinoma: a retrospective cohort study;World Journal of Surgical Oncology;2023-01-30

5. Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data;Neoplasia;2022-12